A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Teikoku Pharma USA
- 05 Oct 2017 Status changed from recruiting to completed.
- 22 Aug 2017 Top-line results published in a Teikoku Pharma USA media release.
- 05 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Aug 2017.